| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2195.18 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1746.53 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1985.83 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2300.81 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1232.86 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1661.37 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1847.81 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2175.09 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1976.21 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1762.46 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1672.62 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1582.44 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2218.74 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1754.88 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1304.26 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1765.11 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1471.82 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1566.76 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1654.18 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1772.6 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1943.5 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1971.14 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1398.64 | 97 |